About this trial
The objective of this international prospective observational study is to evaluate the implementation of a point-of-care digital rectoscope (LumenEye) into routine care to detect colorectal anastomotic leakage in the early postoperative period.
The study includes patients undergoing a colorectal resection with colorectal or coloanal anastomosis ≤15 centimeters from the anorectal junction. The participating centers consist of expert colorectal units in various countries.
The primary endpoint for the study is the time to diagnosis of anastomotic leakage.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
≥ 18 years of age
The participant underwent an open or minimally invasive, sphincter preserving surgery with the construction of a colorectal or coloanal anastomosis ≤15 centimetres from the anorectal junction.
Adequate comprehension of the country specific or English language
Written informed consent
Disqualifiers
None
Trial population
The study population comprises patients undergoing a colorectal resection with anastomosis.
Trial design
Cohort
Prospective
Treatments tested in this trial
Routine endoscopic anastomosis inspection
DeviceThe routine care pathway for early detection of anastomotic leakage includes: * C-reactive protein guided imaging * Rectoscopy of the anastomosis three to six days after surgery * Rectoscopy of the anastomosis two to three weeks after surgery
Treatment groups
Trial outcomes
Primary outcomes
Time to diagnosis of anastomotic leakage
Secondary outcomes
Diagnostic accuracy of point-of-care rectoscopy for detection of AL
Determination of the sensitivity, specificity, negative- and positive predictive values for detecting AL with regards to CT-scan, flexible endoscopy and clinical findings
Patient reported comfort score for diagnostic endoscopy (Gloucester Comfort Scale),
a score of 1 refers to no discomfort while 5 is associated with severe discomfort
Hospital costs of the diagnostic protocol for detection of AL
The direct hospital costs related to the diagnostics aimed at detecting AL
Readmission rate
Sponsors and contacts
Click on the lead sponsor to view all of their trials.